Search the Archive

Medicine: Diabetes Drug #181368

ABC Evening News for Monday, Jul 27, 1998
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) Report introduced.

(New York: John Mckenzie) Questions about the new diabetes drug Rezulin examined; report from Warner Lambert on liver problems due to the drug following the FDA's fast-track review and the need for doctors to monitor patients taking Rezulin noted. [Public Citizen's Health Dr. Sidney WOLFE - calls for the drug to be taken off the market.] [University of Michigan Douglas GREENE - expresses concern.] [Warner-Lambert vice president Anthony WILD, State University of New York Dr. Harold LEBOVITZ - offer views on the monitoring program.] [Ohio State University Dr. Kwame OSEI - comments on the drug's use.]

Jennings, Peter;
Mckenzie, John

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.